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Helicobacter pylori, is an invariably commensal resident of the gutmicrobiome associated with gastric ulcer
in adults. In addition, these patients also suffered from a low grade inflammation that activates the immune
system and thus increased shunting of energy to host defense mechanisms. To assess whether a H. pylori
infection could affect growth in early life, we determined the expression levels of selected metabolic gut
hormones in germ free (GF) and specific pathogen-free (SPF) mice with and without the presence of H.
pylori. Despite H. pylori-infected (SPFH) mice display alteration in host metabolism (elevated levels of
leptin, insulin and peptide YY) compared to non-infected SPFmice, their growth curves remained the same.
SPFHmice also displayed increased level of eotaxin-1. Interestingly, GFmice infected with H. pylori (GFH)
also displayed increased levels of ghrelin and PYY. However, in contrast to SPFH mice, GFH showed
reduced weight gain and malnutrition. These preliminary findings show that exposure to H. pylori alters
hostmetabolism early in life; but the commensal microbiota in SPFmice can attenuate the growth retarding
effect from H. pylori observed in GF mice. Further investigations of possible additional side effects of H.
pylori are highly warranted.
T
he largest human microbiome is the digestive tract, more accurately the large intestine. It harbors approxi-
mately 100 trillion (1014) bacterial cells and more than a 100 times the quantity/number of genes of the
human genome1. We acquired the gut microbiota at the time of birth or immediately after birth and its
composition depends on many factors, including the genetic background, environment and diet1,2. The micro-
biome is usually heterogeneous during the first day of life, and after the first week, a stable bacterial flora will be
established3. The composition and complexity of the microbiome can be affected by physiological changes, such
as aging and pregnancy3,4. Antibiotic treatment and metabolic, immunological or infectious diseases will also
change the gut microbiota5. The gut microbiota plays a significant role in many vital functions, such as energy
harvest from the diet and energy storage4,5, development and regulation of the gut-associated mucosal immune
system3, regulation of the central nervous system6, detoxification of xenobiotics and carcinogens, and protection
against colonization by pathogens7. Alteration of fecal and intestinal mucosal microbiome may also be a cause of
inflammatory bowel disease, obesity and metabolic syndrome. A recent study comparing germ-free (GF) mice
(absence of normal gut microbiota) and their specific pathogen free (SPF) counterparts (with normal gut
microbiota) showed that the absence of normal gutmicrobiota could affect themice’s behavior and the expression
of genes that regulate motor control and anxiety8. Interestingly, in the same study, the authors also demonstrated
that GF mice inoculated with normal gut microbiota early in life displayed similar characteristics as SPF mice.
Thus, they postulated that normal gutmicrobiotamight be responsible formodulating brain development during
early stages of life.
The ancient gastric pathogen, Helicobacter pylori, is a key member of the human gastric microbiome. It co-
evolved with the human race and our association withH. pylori could be traced as early back as 60,000 years ago9.
Furthermore, it resides in the stomach of more than half of the global population regardless of ethnicity and
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colonization is life-long unless eradicated through medical interven-
tion9. Although most carriers remain asymptomatic, about 20% of
them eventually develop gastro-duodenal diseases (such as chronic
gastritis, peptic ulcer and gastric adenocarcinoma) in the later stages
of life11. Many factors, including H. pylori, gut microbiota, the host
and the environment, may contribute to the development of H.
pylori-associated diseases.
In this study, we aimed to investigate the interplay between H.
pylori and normal gut microbiota during early stages of life using GF
and SPF mice models. In order to understand the influences of H.
pylori and normal gut microbiota on the development of metabolic
and immune systems, we assessed the changes of gut metabolic hor-
mones and cytokines/chemokines in response to H. pylori coloniza-
tion in both GFH and SPFH mice.
Results and Discussion
We recovered H. pylori from inoculated SPFH and GFH mice at 2-,
8- and 16-weeks post-colonization. This showed thatH. pylori strain
298 successfully colonized the stomach of the mice inoculated with
this organism. On the other hand, none of the SPF and GF mice was
positive for H. pylori.
In this study, wemeasured the weight of the control SPF,H. pylori-
colonized SPFH, control GF andH. pylori-colonized GFHmice at 2-,
8- and 16-weeks post-colonization (Figure 1). At the end of 16 weeks,
neither SPF nor SPFHmice suffered from any significant weight loss
(p . 0.05). However, GFH mice suffered from significant retarded
weight gain compared to GFmice (p, 0.01). This showed that in the
absence of normal gut microbiota, H. pylori colonization caused
significant reduced weight gain. GF mice weighed significantly less
compared to their SPF counterparts (p , 0.01), which is consistent
with previous reports from other research groups12,13. Earlier studies
have shown that germ-free mice needed 30% more calories com-
pared to conventional mice in order to keep a similar body mass12.
Similarly, another study demonstrated that germ-free mice ate more
but had considerably less body fat than conventional mice13. In the
same study, germ-free mice that were inoculated with microbiota
harvested from the distal intestine (cecum) of conventionally raised
mice gained 60% of body fat. Indeed, normal gut microbiota plays an
important role in determining energy harvest from the diet and
energy storage in its host. However, the role of H. pylori and its
interaction with normal gut microbiota have not been studied.
Gut Microbiota and H. pylori influenced Leptin and Ghrelin
Levels. Leptin and ghrelin, along with many other hormones,
participate in the complex process of energy homeostasis. Ghrelin
(‘‘hunger hormone’’) was originally isolated from the stomach, but
ghrelin has also been identified in other peripheral tissues, such as the
pancreas, ovary and adrenal cortex14. In the brain, ghrelin-producing
neurons have been identified in the pituitary and the hypothalamus
glands15. In the stomach and small intestine, ghrelin is released into
circulation as acyl-ghrelin16. Leptin (‘‘satiety hormone’’) is produced
mainly in the adipocytes of white adipose tissue. Brown adipose
tissue, syncytiotrophoblasts in the placenta, ovaries, skeletal
muscle, stomach (the lower part of the fundic glands), mammary
epithelial cells, bonemarrow, pituitary, liver, gastric chief cells and P/
D1 cells also produce leptin17. Both ghrelin and leptin receptors are
localized on the same brain cells (mainly in the hypothalamus),
therefore these cells receive competing signals of satiety and
hunger18. In this study, we showed that fasting plasma samples of
GF and GFH mice had significantly higher ghrelin level by 16 weeks
into the experiment than SPF and SPFHmice (p, 0.01), whether or
not they wereH. pylori colonized (Figure 2A). Therefore, normal gut
microbiota, but not H. pylori, had significant influence on mice’s
ghrelin level. On the contrary, GF mice had significantly lower
leptin level than SPF mice (p , 0.05) (Figure 2B). Normal gut
microbiota, independent of H. pylori, was sufficient to up-regulate
leptin production and down-regulate ghrelin secretion.
In addition, H. pylori colonization caused significantly increased
leptin production in SPFH mice compared to SPF mice (p , 0.01),
which became obvious by 8-week post-colonization (Figure 2B). In
contrast,H. pylori did not cause higher leptin secretion in GFHmice
compared to GFmice in the absence of normal gut microbiota. Thus,
H. pylori and normal gut microbiota resulted in up-regulated leptin
but not ghrelin production in SPFH mice.
Normal GutMicrobiota andH. pylori induced Insulin Production.
Gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1
(GLP-1) belong to a class of molecules referred as incretins. L-cells
in the ileum secrete GLP-1 postprandial19 while K-cells, which are
found in the mucosa of the duodenum and the jejunum, synthesize
GIP20. The incretins play an important role in stimulating insulin
production in response to the presence of nutrients in the intestine.
Pancreatic ß-islet cells produce insulin, which is the most essential
hormone controlling glucose and energy homeostasis21. Normal gut
microbiome could contribute nutrients and energy to the host via the
fermentation of non-digestible dietary components, thereby directly
stimulating insulin production in the host. Actions of insulin on cells
include: (1) prompting the uptake and storage of glucose in liver and
muscle cells in the form of glycogen, (2) prompting fat cells to take in
blood lipids and converting to triglycerides, (3) prompting adipose
tissue to synthesize fats (i.e., triglycerides) from fatty acid esters, (4)
prompting cells to absorb circulating amino acids, and (5) decreasing
protein breakdown22. Insulin has a stimulatory effect on leptin,
which is produced by fat cells22. In turn, leptin acts on receptors in
the hypothalamus, where it inhibits hunger by (1) counteracting
the effects of neuropeptide Y, (2) counteracting the effects of
anandamide, and (3) promoting the synthesis of a-melanocyte-
stimulating hormone (a-MSH)23. Leptin also interacts with amylin
to reduce gastric emptying and creating a feeling of fullness24. They
work together to maintain energy homeostasis.
We showed that GLP-1 was significantly lower in SPF, SPFH and
GFHmice in comparison toGFmice (p, 0.05) whenmeasured at 8-
and 16-weeks post-colonization (Figure 2C). A similar trend was also
observed for another member of the incretin family, GIP. However,
the increase of GIP in GF mice was not statistically significant
(Figure 2D). This suggested that microbial colonization (H. pylori
or normal gut microbiota alone or together) down-regulated the
expression of host GLP-1 or accelerated the degradation of incretins.
However, insulin level in our study did not correlate with levels of the
incretins. Fasting plasma insulin was low in GF mice despite higher
levels of incretins (Figure 2E). Fasting insulin level was significantly
higher in 16-week SPF mice than in GF mice (p , 0.01), suggesting
that normal gut microbiota could influence circulating insulin level.
Figure 1 | Mean body mass of mice. GF mice weighed significantly less
compared to their SPF counterparts (p , 0.01). At the end of 16 weeks,
neither SPF nor SPFH mice suffered from any significant weight loss
(p . 0.05). However, GFH mice suffered from significant weight loss
compared to GF mice (p , 0.01).
www.nature.com/scientificreports
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Figure 2 | Fasting levels of hormones related to energy homeostasis and eotaxin-1. (A) GF and GFH mice had significantly higher ghrelin level by 16
weeks into the experiment than SPF and SPFHmice (p, 0.01). (B) GFmice had significantly lower leptin level than SPFmice (p, 0.05). Both 8- and 16-
weeks SPFH mice had significantly increased leptin production compared to SPF mice (p, 0.01). (C) GLP-1 was significantly lower in SPF, SPFH and
GFH mice in comparison to GF mice (p , 0.05) at 8- and 16-weeks post-colonization. (D) Increase of GIP in GF mice was not statistically significant
((p , 0.05). (E) Fasting insulin level was significantly higher in 16-week SPF mice than in GF mice (p , 0.01). SPFH mice showed increased insulin
production compared to SPF mice (p , 0.05). (F) PYY level was significantly suppressed in SPF mice by 8 weeks and onwards into the experiment
(p, 0.01) but were significantly higher in SPFH andGFHmice compared to SPF (p, 0.05) andGF (p, 0.01)mice. Fasting PYY level was highest among
GFH mice followed by those of GF mice. (G) The level of chemokine, eotaxin-1, was found to be highest in SPFH mice (p , 0.01) at 16 weeks post-
colonization (Figure 2G).
www.nature.com/scientificreports
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Furthermore, SPFHmice showed increased insulin production com-
pared to SPF mice (p, 0.05). Interestingly, leptin and insulin levels
in plasma of GFH mice were not altered.
PYY induced byH. pylori but suppressed by Normal GutMicrobiota.
Peptide YY (PYY) is found in L cells in the mucosa of gastrointestinal
tract, especially in the ileum and colon. In addition, a small amount of
PYY, about 1–10%, is found in the esophagus, stomach, duodenum and
jejunum25. Like leptin, PYY exerts its action through NPY receptors to
slow the gastric emptying that increases the efficiency of digestion and
nutrient absorption after a meal26. Interestingly, the presence of normal
gut microbiota in SPF mice appeared to suppressed fasting PYY level
significantly by 8 weeks and onwards into the experiment (p , 0.01)
(Figure 2F). On the other hand, H. pylori appeared to up-regulate PYY
production, such that fasting level was significantly higher in SPFH and
GFH mice compared to SPF (p , 0.05) and GF (p , 0.01) mice.
Fasting PYY level was highest among GFHmice followed by those
of GF mice (Figure 2F). High PYY is usually associated with the
consumption of protein and was observed in experimental subjects
to reduce hunger and promote weight loss27. This would help to
explain the weight-loss experienced with high-protein diets.
Therefore, it was not surprising that in this study, we found an
inverse correlation between PYY level and the degree of weight loss.
Since high level PYY was not linked to high protein diets, it might
suggest increased endogenous protein degradation and therefore a
loss of body mass. Another factor that might be indirectly linked to
the retarded weight gain observed in GF mice is ghrelin, which
represents the host’s response by decreasing energy expenditure.
Individuals with anorexia nervosa have high plasma level of ghrelin
compared to individuals who are constitutionally thin as well as
normal-weight controls28. Together, high ghrelin and high PYY
could account for the retarded weight gain in GF and GFH mice
and the animals that might be in a state of malnutrition.
The impact of H. pylori on the composition and function of the
normal gut microbiome has not been fully elucidated. Nevertheless,
in this study, our preliminary results demonstrated that H. pylori
may alter the energy homeostasis of its host, and that the normal
gut microbiome could make a difference on the effect ofH. pylori on
its host.
Gut Metabolic Hormones and Body Mass. A meta-analysis
reporting on H. pylori and obesity prevalence rates in random
population samples of more than 100 human subjects and
discovered there was an inverse correlation between prevalence of
the bacteria and rate of overweight/obesity in developed countries29.
Earlier, circulating meal-associated leptin and ghrelin levels were
shown to change after H. pylori eradication in human volunteers
with an associated increase in body mass intex (BMI) providing
evidence that H. pylori colonization might regulate ghrelin and
leptin levels, which affects body morphometry30. In this study, H.
pylori colonization in young GFmice was shown to result in reduced
gain in body mass.
SPFHmice had significantly higher fasting leptin, insulin and PYY
than SPF mice. Despite the differences in hormonal levels, SPFH
mice had normal body mass. We postulate that H. pylori-associated
up-regulation of PYY stimulated the host to produce more insulin
and leptin in response, thus sustaining normal body mass. However,
the long-term implications of higher fasting PYY, insulin and leptin
remain to be determined. On the other hand, GF and GFHmice had
higher ghrelin, lower leptin and lower insulin than SPF and SPFH
mice. In addition, 16-week GFH mice had higher PYY level than GF
mice. All these hormonal differences between GF and GFH mice in
comparison to SPF and SPFH mice might be linked to their body
masses. Interestingly, the effect of H. pylori on body mass was most
obvious in GFH mice in the absence of normal gut microbiota.
The relationship between body mass and different gut metabolic
hormones/eotaxin-1 was determined (Table 1). Leptin and PYY
levels were shown to be significantly related (p, 0.05) to body mass
in both 8-week and 16-week mice in direct and inverse relationships
respectively. However, ghrelin and insulin levels were not related to
body mass at 8 weeks (p$ 0.05) but were significantly inversely and
directly correlated respectively in 16-week mice (p , 0.05).
Surprisingly, eotaxin-1 levels correlated significantly with body mass
initially at 8 weeks (p, 0.05) but not at the later 16 weeks (p$ 0.05).
These results suggest that both leptin and PYY influenced body mass
at an early stage and continue to do so at later stage. On the other
hand, ghrelin and insulin, which became related to bodymass only at
a later stage, might be in responds to the initial changes in leptin and
PYY levels. Eotaxin-1 might be an indirectly respond to the initial
change in body mass but still have an important influence on the
early development in these young mice.
In our study, H. pylori infection in GFH mice was associated with
high plasma PYY level. Thismay signify high energy expenditure and
high rate of metabolism in these mice, which translate to rapid loss of
bodymass. However, the presence of normal gutmicrobiota in SPFH
mice might provide buffering against the direct adverse impact ofH.
pylori on body mass. On the other hand, high level of leptin in SPFH
mice might suppress food intake and thereby preventing the mice
from becoming obese over long term. Results on SPFH mice from
this study is consistent with the observation in human subjects that
H. pylori eradication resulted in increased BMI30. Thus, H. pylori
regulating metabolic hormones may play a role in keeping obesity
at bay.
Possible Impacts of Gut Microbiota andH. pylori on Early Develop-
ment. Heijtz et al. reported that the same GF mice used in this study
demonstrated increasedmotor activity and reduced anxiety compared
to SPF mice8. This correlated with altered expression of genes
regulating motor control and anxiety-like behavior. The same
report also demonstrated that GF mice exposed to normal gut
microbiota early in life had similar characteristics to those of SPF
mice. This observation might be related to impaired nutritional
absorption in the GF mice in the absence of normal gut microbiota,
which led to malnutrition and weight loss. It is well known that the
Table 1 | Parametric Pearson correlation between levels of hormones related to energy homeostasis/chemokines and body mass accom-
panied by two-tailed p-values
8 Weeks 16 Weeks
Correlation Coefficient Significance (2-tailed) Correlation Coefficient Significance (2-tailed)
Ghrelin 20.344 0.364 20.803* 0.016
Leptin 0.724* 0.027 0.788* 0.020
Insulin 0.586 0.098 0.838** 0.009
PYY 20.732* 0.025 20.873** 0.005
Eotaxin 0.787* 0.012 0.431 0.286
*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the 0.01 level (2-tailed).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 8731 | DOI: 10.1038/srep08731 4
nutritional level has a direct impact on early developmental stages
(including brain and mentor development). Furthermore, ghrelin
knockout mice had been shown to have increased anxiety in
response to a variety of stressors, such as acute restraint stress and
social stress, in experimental settings31. Higher ghrelin level in GF
mice might also explain the altered behavior in GF mice reported
by Heijtz et al.
Increased eotaxin-1 level in blood plasma is also associated with
aging in mice and humans32. It has been demonstrated that exposing
youngmice to eotaxin-1 or the blood plasma of older mice decreased
their neurogenesis and cognitive performance in behavioral tasks,
which are dependent on neurogenesis in the hippocampus32.
Interestingly, a large population cohort retrospective study in
Denmark has established a correlation between chronic H. pylori
and/or gastritis and Parkinson’s disease33. The level of chemokine,
eotaxin-1, was found to be highest in SPFH mice (p , 0.01) at 16-
week post-colonization (Figure 2G). Eotaxin-1 is one of the chemo-
kines thatmediates eosinophil migration, a prominent component of
H. pylori–induced gastritis34. Thus, high level of eotaxin-1 in SPFH
mice led us to hypothesize that these chemokines served as early
indication of inflammation and the interplay between H. pylori
and normal gut microbiota may intensify chronic inflammation.
Therefore, it is possible that H. pylori exposure during early devel-
opmental stages will have long-term implication on brain develop-
ment. Unfortunately, we did not carry out any behavioral study or
motor control tests in this study for confirmation.
In conclusion, this study in SPF and GF mice with and withoutH.
pylori imply that the gastric pathogen, H. pylori, interacts with nor-
mal gut microbiota, which alters metabolic and inflammatory path-
ways on SPFH mice compared to SPF mice (Figure 3). Our results
also suggest that there is an ongoing crosstalk between H. pylori and
the normal gut microbiota which associates with gut inflammation.
Previous data have established causality betweenH. pylori and gastric
ulcer and stomach cancer. The data presented in this study, connect-
ing H. pylori to crosstalk with the normal gut microbiota, imply that
the onset ofH. pylorimediated diseases in humans is more complex.
Additional experiments are therefore highly warranted, in particular
in early life.
Methods
H. pylori Strain and Inoculum Preparation. The C57BL/6 mice-adapted H. pylori
strain, 298, was used in this study. The genome of this strain has been fully
sequenced35. Briefly, H. pylori was cultured in Brain Heart Infusion Broth
supplemented with 0.4% yeast extract and 1% ß-cyclodextran (BHYC) for 4 days at
Figure 3 | Diagrammatic representation of the effect of normal gut microbiota and H. pylori in mice. Normal gut microbiota plays an important role
regulation of gut metabolic hormone homeostasis that affects the development of normal body mass and brain. In addition, normal gut microbiota
also influences the outcome of H. pylori colonization by affecting the gut metabolic hormone changes and inflammation induced by H. pylori.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 8731 | DOI: 10.1038/srep08731 5
37uC in a humidified 10% CO2 incubator. The bacteria count was adjusted to the
concentration of 109 bacteria per ml to be used for animal inoculation.
Animals and Inoculation. Male SPF and GF C57BL/6 mice of 4–6 weeks old were
used for experiments.Malemice were used because they have been reported to show a
higher incidence of intestinal-type gastric carcinoma than females36. All mice (SPF
and GF) were maintained in sterile plastic isolators at the National Cancer Centre’s
germ-free facility (NCC) housed in the SingHealth Experimental Medicine Centre.
Animals were maintained on autoclaved R36 Lactamin Chow (Lactamin, Sweden)
and kept under 12-h light cycles condition. The animals were divided into four groups
of 12 (SPF, SPFH, GF and GFH). SPF and GFmice for inoculation withH. pyloriwere
fasted overnight and fed intragastrically with 0.1 ml of bacterial culture three times
with a 1-day interval in between. Control animals were inoculated with sterile BHYC
media in the sameway. Subsequently, mice were sacrificed 2 weeks (N5 3 per group),
8 weeks (N 5 5) and 16 weeks (N 5 5) post-colonization. Mouse gastrics were
collected for H. pylori culturing, and plasma was used for hormone and cytokine
analysis.
Ethics Statements. All experimental procedures were approved and carried out in
accordance to the regulations and guidelines of the SingHealth Institutional Animal
Care and Use Committee (IACUC; Application #2011/SHS/680) and National
Cancer Centre Singapore Research Biosafety Committee/SingHealth Institutional
Biosafety Committee (IBS; Application #010/RBC/2011).
Plasma Sample Collection. Blood was drawn into pre-chilled EDTA-coated tubes
and mixed gently by inversion. Blood was transferred into a chilled Eppendorf tube
containing 2 M 4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride (AEBSF,
Sigma-Aldrich, Buchs, Switzerland) to a final concentration of 0.2 M and mixed
gently. The tube was centrifuged at 3,0003 g for 3 min (4uC). The resultant plasma
was added to a cryotube containing 1N HCl to give a final concentration of 0.1N and
was stored at 280uC until analysis.
CulturingH. pylori from mouse gastric stomach was homogenized and inoculated
onto chocolate agar plates supplemented with 7% lysed horse blood and, in the case of
selective media, trimethoprim (5 mg/ml), vancomycin (10 mg/ml), nalidixic acid
(20 mg/ml) and amphotericin B (5 mg/ml), were added. All the antibiotics were from
Sigma-Aldrich Corporation (St. Louis, MO, USA). The agar plates were simulta-
neously incubated at 37uC under humidified conditions with 10% carbon dioxide.H.
pylori-like colonies were confirmed by positivity with urease, oxidase and catalase
tests.
Multiplex Assay for Gut Hormones and Cytokines. Milliplex MAP Kit for Mouse
Metabolic Magnetic Bead Panel (Catalogue#MMHMAG-44K; Millipore Corp., MO,
USA) was used to quantify eight gut hormones that are important regulators of food
intake, energy expenditure and body mass: acylated (active) ghrelin, leptin, active
amylin, insulin, active glucagon-like peptide-1 (GLP-1), total gastric inhibitory
polypeptide (GIP), total peptide YY (PYY) and pancreatic polypeptide (PP). Mouse
Cytokine/Chemokine Magnetic Bead Panel (Catalogue# MPXMCYTO-70K;
Millipore Corp., MO, USA) was used to measure a panel of 32 different mouse
cytokines/chemokines. Plasma was used and assays were carried out according to
manufacturer’s instructions. Measurement was performed on Luminex 200TM system
with xPONENTTM software, version 3.1 (Luminex, Austin, TX, USA).
Statistical analysis. Statistical analyses were performed using the IBM SPSS version
22.0 software. One-way ANOVA (alpha 5 0.05) and Tukey’s honestly significant
difference (HSD) post-hoc test were performed. Parametric Pearson correlation was
carried out. P-value of , 0.05 was considered significant.
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